Detalhe da pesquisa
1.
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/ß2m overexpression.
Mod Pathol
; 33(3): 468-482, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409873
2.
High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis.
Front Oncol
; 11: 684478, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211852
3.
Gastrointestinal Cancers--2007 symposium. Multidisciplinary approaches to the prevention, diagnosis and therapy of GI cancers.
IDrugs
; 10(3): 159-61, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17351865